Austin Doyle
Impact in
- Neurology top 5%
- Neurofibromatosis and Schwannoma Cases
- Ophthalmology top 2%
- Ocular Oncology and Treatments
Papers in
- Oncology 9
- Lung Cancer Research Studies 3
- Cancer Treatment and Pharmacology 2
-
- Acute Myeloid Leukemia Research 3
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Adi F. Gazdar (2 shared papers)Keiko Funa (1 shared paper)Ilona R. Linnoila (1 shared paper)W John Martin (1 shared paper)Frank F. Cuttitta (1 shared paper)Paul A. Bunn (1 shared paper)SE Martin (1 shared paper)James L. Mulshine (2 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Blood (3 papers)Annals of Oncology (3 papers)Investigational New Drugs (2 papers)Neuro-Oncology (2 papers)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Austin Doyle
30 papers receiving 2.1k citations
Austin Doyle's Hit Papers
Peers
Comparison fields: 5 of 73
- Neurology 397
- Ophthalmology 230
- Oncology 400
- Pulmonary and Respiratory Medicine 321
- Immunology 185
Countries citing papers authored by Austin Doyle
This map shows the geographic impact of Austin Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Austin Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Austin Doyle more than expected).
Fields of papers citing papers by Austin Doyle
This network shows the impact of papers produced by Austin Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Austin Doyle. The network helps show where Austin Doyle may publish in the future.
Co-authors
The 25 scholars most cited alongside Austin Doyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas Hit paper breakdown → | 2016 | 532 |
| 2 | Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma Hit paper breakdown → | 2014 | 358 |
| 3 | 1985 | 349 | |
| 4 | 2015 | 197 | |
| 5 | 2004 | 124 | |
| 6 | 2015 | 69 | |
| 7 | 2006 | 67 | |
| 8 | 2016 | 65 | |
| 9 | 2015 | 48 | |
| 10 | 2019 | 47 | |
| 11 | 2015 | 44 | |
| 12 | 2011 | 43 | |
| 13 | 2011 | 37 | |
| 14 | 2007 | 36 | |
| 15 | 2013 | 32 | |
| 16 | 2010 | 26 | |
| 17 | 1986 | 20 | |
| 18 | 2001 | 17 | |
| 19 | 2016 | 11 | |
| 20 | 2010 | 10 |
About Austin Doyle
Austin Doyle is a scholar working on Oncology, Hematology, Immunology, Ophthalmology and Statistics and Probability, having authored 30 papers that have together received 2.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Lung Cancer Research Studies (3 papers), Ocular Oncology and Treatments (2 papers), Esophageal Cancer Research and Treatment (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Neurology (397 citations), Ophthalmology (230 citations), Oncology (400 citations), Pulmonary and Respiratory Medicine (321 citations) and Immunology (185 citations). Austin Doyle has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Adi F. Gazdar, Keiko Funa, Ilona R. Linnoila, W John Martin, Frank F. Cuttitta, Paul A. Bunn, SE Martin, James L. Mulshine, D Carney and Mark J. Krasna. Their work appears in journals such as Clinical Cancer Research, Blood, Annals of Oncology, Investigational New Drugs and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.